Medicine injector
Latest Novartis AG Patents:
- Modified release formulation for (-)-(3AR,4S,7AR)-4-hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester
- Polyomavirus neutralizing antibodies
- Synthesis of prostate specific membrane antigen (PSMA) ligands
- Cell secreted minibodies and uses thereof
- Combination therapy using a chimeric antigen receptor
Description
The broken lines shown in
Claims
The ornamental design for a medicine injector, as shown and described.
Patent History
Patent number: D677381
Type: Grant
Filed: Jun 12, 2012
Date of Patent: Mar 5, 2013
Assignee: Novartis AG (Basel)
Inventors: Nicholas Charles Stones (Basel), Martin James Dinnage (Cambridge), Serge Roux (Cambridge, MA), Jeremy Alan Van Hill (Boston, MA), Timothy Duncan Wooller (London), Andy Duncan Pidgeon (Cambridge), Alan Leslie Hawkins (Kent)
Primary Examiner: David Muller
Application Number: 29/424,442
Type: Grant
Filed: Jun 12, 2012
Date of Patent: Mar 5, 2013
Assignee: Novartis AG (Basel)
Inventors: Nicholas Charles Stones (Basel), Martin James Dinnage (Cambridge), Serge Roux (Cambridge, MA), Jeremy Alan Van Hill (Boston, MA), Timothy Duncan Wooller (London), Andy Duncan Pidgeon (Cambridge), Alan Leslie Hawkins (Kent)
Primary Examiner: David Muller
Application Number: 29/424,442
Classifications
Current U.S. Class:
Hand Actuated Flow Control (e.g., Lever, Button, Etc.) (D24/113)